ABCL
Price
$4.24
Change
+$0.35 (+9.00%)
Updated
Jul 10, 01:14 PM (EDT)
Capitalization
1.26B
28 days until earnings call
CARM
Price
$0.40
Change
-$0.00 (-0.00%)
Updated
Jul 10, 04:59 PM (EDT)
Capitalization
16.63M
Interact to see
Advertisement

ABCL vs CARM

Header iconABCL vs CARM Comparison
Open Charts ABCL vs CARMBanner chart's image
AbCellera Biologics
Price$4.24
Change+$0.35 (+9.00%)
Volume$600
Capitalization1.26B
Carisma Therapeutics
Price$0.40
Change-$0.00 (-0.00%)
Volume$100
Capitalization16.63M
ABCL vs CARM Comparison Chart in %
Loading...
ABCL
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
CARM
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
View a ticker or compare two or three
VS
ABCL vs. CARM commentary
Jul 10, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is ABCL is a Hold and CARM is a Hold.

Interact to see
Advertisement
COMPARISON
Comparison
Jul 10, 2025
Stock price -- (ABCL: $4.22 vs. CARM: $0.40)
Brand notoriety: ABCL and CARM are both not notable
Both companies represent the Biotechnology industry
Current volume relative to the 65-day Moving Average: ABCL: 118% vs. CARM: 3%
Market capitalization -- ABCL: $1.26B vs. CARM: $16.63M
ABCL [@Biotechnology] is valued at $1.26B. CARM’s [@Biotechnology] market capitalization is $16.63M. The market cap for tickers in the [@Biotechnology] industry ranges from $314.48B to $0. The average market capitalization across the [@Biotechnology] industry is $2.43B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

ABCL’s FA Score shows that 0 FA rating(s) are green whileCARM’s FA Score has 0 green FA rating(s).

  • ABCL’s FA Score: 0 green, 5 red.
  • CARM’s FA Score: 0 green, 5 red.
According to our system of comparison, ABCL is a better buy in the long-term than CARM.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

ABCL’s TA Score shows that 4 TA indicator(s) are bullish while CARM’s TA Score has 5 bullish TA indicator(s).

  • ABCL’s TA Score: 4 bullish, 4 bearish.
  • CARM’s TA Score: 5 bullish, 5 bearish.
According to our system of comparison, both ABCL and CARM are a good buy in the short-term.

Price Growth

ABCL (@Biotechnology) experienced а +12.53% price change this week, while CARM (@Biotechnology) price change was -5.24% for the same time period.

The average weekly price growth across all stocks in the @Biotechnology industry was +9.89%. For the same industry, the average monthly price growth was +16.25%, and the average quarterly price growth was +20.89%.

Reported Earning Dates

ABCL is expected to report earnings on Nov 11, 2025.

CARM is expected to report earnings on May 13, 2025.

Industries' Descriptions

@Biotechnology (+9.89% weekly)

Biotechnology involves genetic or protein engineering to produce medicines/therapies for treating and preventing ailments. The industry also provides crucial ingredients for diagnostics. This multi-billion-dollar industry is heavily focused on research and development, as companies attempt to continually come up with cutting-edge solutions for health. New discoveries for the treatment of diseases provide opportunities for growth for a company in this industry. Discoveries, however, must pass the regulatory approval from the U.S. Food and Drug Administration (FDA) before they can make it to markets. Amgen Inc., Gilead Sciences, Inc. and Celgene Corporation are examples of companies in this industry.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
ABCL($1.26B) has a higher market cap than CARM($16.6M). ABCL YTD gains are higher at: 44.027 vs. CARM (-4.967). CARM has higher annual earnings (EBITDA): -49.68M vs. ABCL (-211.2M). ABCL has more cash in the bank: 605M vs. CARM (7.74M). CARM has less debt than ABCL: CARM (2.33M) vs ABCL (67.8M). ABCL has higher revenues than CARM: ABCL (23.1M) vs CARM (20M).
ABCLCARMABCL / CARM
Capitalization1.26B16.6M7,590%
EBITDA-211.2M-49.68M425%
Gain YTD44.027-4.967-886%
P/E RatioN/AN/A-
Revenue23.1M20M116%
Total Cash605M7.74M7,817%
Total Debt67.8M2.33M2,916%
FUNDAMENTALS RATINGS
CARM: Fundamental Ratings
CARM
OUTLOOK RATING
1..100
92
VALUATION
overvalued / fair valued / undervalued
1..100
93
Overvalued
PROFIT vs RISK RATING
1..100
100
SMR RATING
1..100
100
PRICE GROWTH RATING
1..100
35
P/E GROWTH RATING
1..100
100
SEASONALITY SCORE
1..100
n/a

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

TECHNICAL ANALYSIS
Technical Analysis
ABCLCARM
RSI
ODDS (%)
Bearish Trend 2 days ago
90%
Bearish Trend 2 days ago
86%
Stochastic
ODDS (%)
Bearish Trend 2 days ago
90%
Bullish Trend 2 days ago
75%
Momentum
ODDS (%)
N/A
Bearish Trend 2 days ago
89%
MACD
ODDS (%)
N/A
Bearish Trend 2 days ago
86%
TrendWeek
ODDS (%)
Bullish Trend 2 days ago
78%
Bearish Trend 2 days ago
89%
TrendMonth
ODDS (%)
Bullish Trend 2 days ago
74%
Bullish Trend 2 days ago
82%
Advances
ODDS (%)
Bullish Trend 4 days ago
76%
Bullish Trend 9 days ago
85%
Declines
ODDS (%)
Bearish Trend 11 days ago
86%
Bearish Trend 4 days ago
90%
BollingerBands
ODDS (%)
Bearish Trend 2 days ago
90%
Bearish Trend 2 days ago
88%
Aroon
ODDS (%)
Bullish Trend 2 days ago
77%
Bullish Trend 2 days ago
84%
View a ticker or compare two or three
Interact to see
Advertisement
ABCL
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
CARM
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
MFs / NAMEPrice $Chg $Chg %
AEMMX12.19N/A
N/A
American Century Emerging Markets A
SFILX15.32N/A
N/A
Schwab Fundamental Intl Sm Eq Idx
MPGSX11.70N/A
N/A
MassMutual Disciplined Gr R5
ADVGX13.33N/A
N/A
North Square Select Small Cap I
URNQX56.00N/A
N/A
Victory Nasdaq 100 Index R6